(CS) AXA - Overview
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: PA (France) | Market Cap: 81.613m EUR | Total Return: 2.5% in 12m
Avg Turnover: 138M
Warnings
Volatile Below Avwap Earnings
Tailwinds
No distinct edge detected
AXA SA is a Paris-based global provider of insurance, asset management, and banking services. Operating across diverse geographical segments including Europe, Asia, and Africa, the company maintains a comprehensive portfolio encompassing life, savings, property, and casualty insurance. Its business model relies heavily on risk diversification through its AXA XL division, which provides specialized reinsurance and commercial coverage for complex liabilities such as environmental, marine, and aviation risks.
The company integrates technology into its service delivery through digital ecosystems, including the AXA Multilink platform and generative AI assistants for customer interaction. As a multi-line insurer, AXA benefits from a balanced revenue stream derived from both retail premiums and institutional asset management fees, a structure common among large-scale European financial conglomerates. For a deeper look into the companys financial health, investors can review detailed valuation metrics on ValueRay.
Founded in 1852, AXA has evolved into a global systemic insurer with a significant presence in both mature and emerging markets. Its operations extend beyond traditional indemnity to include healthcare solutions, teleconsultation services, and integrated risk management consulting for corporate clients.
- AXA XL commercial lines pricing power drives underwriting margin expansion
- High interest rates bolster investment income and life insurance profitability
- European regulatory changes and Solvency II ratios impact capital return capacity
- Expansion of health and protection services increases fee-based revenue streams
- Natural catastrophe frequency and severity volatility affects property and casualty earnings
| Net Income: 15.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.37 > 1.0 |
| NWC/Revenue: 26.18% < 20% (prev 60.26%; Δ -34.08% < -1%) |
| CFO/TA 0.05 > 3% & CFO 33.5b > Net Income 15.6b |
| Net Debt (40.0b) to EBITDA (28.4b): 1.41 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (2.03b) vs 12m ago -8.98% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 27.51% > 50% (prev 29.03%; Δ -1.52% > 0%) |
| Interest Coverage Ratio: 31.30 > 6 (EBITDA TTM 28.4b / Interest Expense TTM 906.0m) |
| A: 0.07 (Total Current Assets 46.1b - Total Current Liabilities 0.0) / Total Assets 636b |
| B: 0.07 (Retained Earnings 41.4b / Total Assets 636b) |
| C: 0.04 (EBIT TTM 28.4b / Avg Total Assets 640b) |
| D: 0.10 (Book Value of Equity 56.7b / Total Liabilities 586b) |
| Altman-Z'' = 1.09 = BB |
| DSRI: 2.57 (Receivables 23.9b/9.90b, Revenue 176b/187b) |
| GMI: 0.97 (GM 105.3% / 102.4%) |
| AQI: 1.23 (AQ_t 0.92 / AQ_t-1 0.75) |
| SGI: 0.94 (Revenue 176b / 187b) |
| TATA: -0.03 (NI 15.6b - CFO 33.5b) / TA 636b) |
| Beneish M = -1.70 (Cap -4..+1) = CCC |
As of May 29, 2026, the stock is trading at EUR 39.72 with a total of 3,399,897 shares traded.
Over the past week, the price has changed by -0.97%,
over one month by +2.73%,
over three months by +1.54% and
over the past year by +2.51%.
AXA has no consensus analysts rating.
P/E Trailing = 11.731
P/E Forward = 9.6993
P/S = 0.8619
P/B = 1.7301
P/EG = 1.2122
Revenue TTM = 176b EUR
EBIT TTM = 28.4b EUR
EBITDA TTM = 28.4b EUR
Long Term Debt = 60.5b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.78b EUR (from shortTermDebt, last fiscal year)
Debt = 62.3b EUR (corrected: LT Debt 60.5b + ST Debt 1.78b)
Net Debt = 40.0b EUR (calculated: Debt 62.3b - CCE 22.2b)
Enterprise Value = 122b EUR (81.6b + Debt 62.3b - CCE 22.2b)
Interest Coverage Ratio = 31.30 (Ebit TTM 28.4b / Interest Expense TTM 906.0m)
EV/FCF = 9.23x (Enterprise Value 122b / FCF TTM 13.2b)
FCF Yield = 10.84% (FCF TTM 13.2b / Enterprise Value 122b)
FCF Margin = 7.49% (FCF TTM 13.2b / Revenue TTM 176b)
Net Margin = 8.89% (Net Income TTM 15.6b / Revenue TTM 176b)
Gross Margin = unknown ((Revenue TTM 176b - Cost of Revenue TTM -9.41b) / Revenue TTM)
Tobins Q-Ratio = 0.19 (Enterprise Value 122b / Total Assets 636b)
Interest Expense / Debt = 1.45% (Interest Expense 906.0m / Debt 62.3b)
Taxrate = 21.88% (1.05b / 4.79b)
NOPAT = 22.2b (EBIT 28.4b * (1 - 21.88%))
Current Ratio = 0.10 (Total Current Assets 46.1b / Total Current Liabilities 457b)
Debt / Equity = 1.32 (Debt 62.3b / totalStockholderEquity, last quarter 47.2b)
Debt / EBITDA = 1.41 (Net Debt 40.0b / EBITDA 28.4b)
Debt / FCF = 3.04 (Net Debt 40.0b / FCF TTM 13.2b)
Total Stockholder Equity = 46.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 15.6b / Total Assets 636b)
RoE = 33.99% (Net Income TTM 15.6b / Total Stockholder Equity 46.0b)
RoCE = 26.62% (EBIT 28.4b / Capital Employed (Equity 46.0b + L.T.Debt 60.5b))
RoIC = 4.62% (EBIT 28.4b / (Assets 636b - Curr.Liab 0.0 - Cash 22.2b))
WACC = 3.94% (E(81.6b)/V(144b) * Re(6.08%) + D(62.3b)/V(144b) * Rd(1.45%) * (1-Tc(0.22)))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -6.97%
[DCF] Terminal Value 77.97% ; FCFF base≈12.3b ; Y1≈14.1b ; Y5≈20.7b
[DCF] Fair Price = 133.7 (EV 312b - Net Debt 40.0b = Equity 272b / Shares 2.03b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.81 | EPS CAGR: 18.42% | SUE: 0.0 | # QB: 0
Revenue Correlation: -20.76 | Revenue CAGR: -4.24% | SUE: 0.21 | # QB: 0
EPS current Year (2026-12-31): EPS=4.12 | Chg30d=-0.24% | Revisions=-27% | GrowthEPS=+6.7% | GrowthRev=+21.9%
EPS next Year (2027-12-31): EPS=4.45 | Chg30d=+0.10% | Revisions=+0% | GrowthEPS=+8.1% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: -27%